Filing Details

Accession Number:
0001181431-12-058111
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-13 09:09:22
Reporting Period:
2012-11-09
Filing Date:
2012-11-13
Accepted Time:
2012-11-13 09:09:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
878526 Natus Medical Inc BABY Electromedical & Electrotherapeutic Apparatus (3845) 770154833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208700 M Kenneth Traverso C/O Natus Medical Incorporated
1501 Industrial Road
San Carlos CA 94070
Vp Marketing And Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2012-11-09 76,042 $3.45 174,045 No 4 M Direct
Common Stock, $0.001 Par Value Per Share Disposition 2012-11-09 49,885 $11.19 125,160 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option Acquisiton 2012-11-09 76,042 $3.45 76,042 $3.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,157 2002-12-02 2012-11-12 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share 8,572 Indirect By Family Trust
Common Stock, $0.001 Par Value Per Share 10,500 Indirect By IRA
Common Stock, $0.001 Par Value Per Share 4,100 Indirect By IRA for Spouse
Footnotes
  1. This transaction reflects the exercise and same day sale of an option that would expire by its terms on November 12, 2012.
  2. This transaction was executed in multiple trades at prices ranging from $11.00 to $11.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The option vests in 48 equal monthly installments beginning on the date of grant.